| Home | E-Submission | Sitemap | Editorial Office
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha
Clin Mol Hepatol.2017;23(1):95-101.   Published online March 24, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0006
      
Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?
Jin Wook Chung
Clin Mol Hepatol.2017;23(1):31-33.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0102
                              
Percutaneous cryoablation for hepatocellular carcinoma
Kyoung Doo Song
Clin Mol Hepatol.2016;22(4):509-515.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0079
                              
Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol.2016;22(4):477-486.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0048
                              
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                              
Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Clin Mol Hepatol.2016;22(4):450-457.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0036
                              
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2016;22(3):359-365.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0033
                              
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0021
                                 Cited By 1
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0104
                              
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0045
                              
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol.2016;22(2):250-258.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0015
                                 Cited By 3
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso
Clin Mol Hepatol.2016;22(2):199-211.   Published online May 18, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0101
                                 Cited By 3
Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis
Ah Yeong Kim, Woo Kyoung Jeong
Clin Mol Hepatol.2016;22(1):192-197.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.192
                              
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee
Clin Mol Hepatol.2016;22(1):160-167.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.160
                                 Cited By 3
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Su Jong Yu
Clin Mol Hepatol.2016;22(1):7-17.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.7
                                 Cited By 13
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Hyun Young Woo, Jeong Heo
Clin Mol Hepatol.2015;21(4):344-348.   Published online December 24, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.4.344
                                 Cited By 1
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Jung Gil Park
Clin Mol Hepatol.2015;21(3):287-294.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.287
                                 Cited By 4
Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
Clin Mol Hepatol.2015;21(3):279-286.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.279
                                 Cited By 4
Influence of P53 on the radiotherapy response of hepatocellular carcinoma
Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão
Clin Mol Hepatol.2015;21(3):257-267.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.257
                                 Cited By 2
P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
Yu Rim Lee, Soo Young Park
Clin Mol Hepatol.2015;21(3):230-231.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.230
                              
The mutational landscape of hepatocellular carcinoma
Ju-Seog Lee
Clin Mol Hepatol.2015;21(3):220-229.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.220
                                 Cited By 9
Personalized management of cirrhosis by non-invasive tests of liver fibrosis
Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong
Clin Mol Hepatol.2015;21(3):200-211.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.200
                                 Cited By 7
The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study
Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim
Clin Mol Hepatol.2015;21(2):165-174.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.165
                                 Cited By 3
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
Kil Hyo Park, Soon Ha Kwon, Yong Sub Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim
Clin Mol Hepatol.2015;21(2):158-164.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.158
                                 Cited By 2
New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
Hyun Young Woo, Jeong Heo
Clin Mol Hepatol.2015;21(2):115-121.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.115
                                 Cited By 6
Hepatitis C virus-induced hepatocellular carcinoma
Nicolas Goossens, Yujin Hoshida
Clin Mol Hepatol.2015;21(2):105-114.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.105
                                 Cited By 14
Recent advances in the imaging of hepatocellular carcinoma
Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee
Clin Mol Hepatol.2015;21(1):95-103.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.95
                              
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm
Clin Mol Hepatol.2015;21(1):85-88.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.85
                                 Cited By 3
Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume
Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim
Clin Mol Hepatol.2015;21(1):71-79.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.71
                              
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2015;21(1):60-70.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.60
                              Supplementary         Cited By 2
1 | 2 | 3 | 4 | 5 | 6 | 7 |
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.